GOEV vs NGNE
GOEV (GOEV) versus Neurogene Inc (NGNE) — a side-by-side from cached financials, not a winner call.
GOEV (GOEV) common stock.
Neurogene Inc (NGNE) is a biotechnology company listed on US.
GOEV does not have a complete income-statement cache yet.
Latest reported NGNE revenue for 2025-09-30 was $0. Net income was -$21.0M. NGNE currently screens at market cap $286.5M.
NGNE currently screens at market cap $286.5M.
Not investment advice. Open the GOEV and NGNE stock pages for the full models.
Not investment advice.